sms helpline whatsapp - 09881300400

Product enquiry

Ariteron -Abiraterone Acetate tablets

Abiraterone Inhibits CYP17 and decreases serum testosterone and other androgens This helps in the treatment of Androgen sensitive prostatic carcinoma patients

Each tablet contains Abiraterone acetate 250 mg.

In combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel.

Dosage and administration:
Recommended dose: 1000 mg administered orally once daily in combination with prednisone 5 mg administered orally twice daily; must be taken on an empty stomach;

For patients with baseline moderate hepatic impairment (Child-Pugh Class B): reduce the starting dose to 250 mg once daily.

HDPE container containing 120 tablets / 30 tablets